Overview
Status
Active
Registry date
2025-02-21
Share capital
5,000.00 PLN
Registered address
ul. Samuela Bogumiła Lindego 1C, 30-148 Kraków, Poland
Email
Electronic delivery address
AE:PL-14978-85638-IUDGD-09
Financials
Filing timeliness
1 of 1 financial statements was filed late (for 2025, 84 days late).
- 202507/10/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 603.58kMedianUSD 344.81kAverageUSD 7.16m
Net profit
This companyUSD -2.33kMedianUSD 4.90kAverageUSD 706.58k
Operating costs
This companyUSD 603.60kMedianUSD 396.72kAverageUSD 6.21m
Assets
This companyUSD 207.48kMedianUSD 356.06kAverageUSD 7.10m
Industry
Authorized Representatives
Damian Marcin Pilich – Management Board Member
Krzysztof Kowaleczko – Management Board Member
Manner of representation
In the case of a multi-member management board, two members of the management board are authorised to represent the company. In the case of a one-person management board, one member of the management board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 70 | $945.43 | 70% | |
Łukasz Jan Kolonkoage 50 | 15 | $202.59 | 15% |
Damian Marcin Pilichage 43 | 15 | $202.59 | 15% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2025-03-13.
27 1050 1908 1000 0090 8477 9975
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 1, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Global Pharma CmS.A. | $24,132,016.98 | globalpharma.pl | ||
| ALG Pharmasp. z o.o. | $16,237,368.88 | algpharma.pl | ||
| Laboratoria Naturysp. z o.o. | $13,931,403.39 | laboratorianatury.pl | ||
| Norsa Pharmasp. z o.o. | $9,111,390.60 | norsapharma.eu | ||
| OnesanoS.A. | $3,063,535.91 | onesano.pl | ||
| Iodica Worldsp. z o.o. | $1,600,922.46 | iodica.pl | ||
| Auralab360sp. z o.o. | $1,385,659.31 | auralab360.pl | ||
| IOCsp. z o.o. | $878,940.46 | producentsuplementow.pl | ||
| Instytut Urządzeń Ekstrakcyjnychsp. z o.o. | $243,885.18 | sfe.com.pl | ||
| Betterme.Biosp. z o.o. | $55,901.95 | betterme.bio |
FAQ
The main business activity of P6 Pharma focuses on manufacture of food supplements.
The company was registered in the Polish National Court Register (KRS) on February 21, 2025.
The headquarters is located at: ul. Samuela Bogumiła Lindego 1C, 30-148 Kraków.
The management board consists of: Damian Marcin Pilich (Member of the Management Board) and Krzysztof Kowaleczko (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from February 21, 2025 to December 31, 2025.
The company reported a revenue of USD 603,575 in 2025.
No, in 2025 the company reported a net loss of USD 2,333.
The largest operating cost category falls under other operating costs. This category amounted to USD 599,650 in 2025, representing 99% of all operating expenses.
Last updated: 2026-10-07